메뉴 건너뛰기




Volumn 13, Issue 24, 2006, Pages 2889-2900

Current pharmacological treatment of nonalcoholic fatty liver

Author keywords

Antioxidants; Glitazones; Insulin resistance; Liver steatosis; Orlistat; Probiotics; Rimonabant; Sibutramine

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANOREXIGENIC AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; BETAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENFLURAMINE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; PENTOXIFYLLINE; PHENTERMINE; PHOSPHATIDYLCHOLINE; PIOGLITAZONE; RIMONABANT; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SIBUTRAMINE; SILIBININ; SULFONYLUREA; TETRAHYDROLIPSTATIN; TROGLITAZONE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

EID: 33749448166     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986706778521878     Document Type: Review
Times cited : (49)

References (154)
  • 18
    • 0037126526 scopus 로고    scopus 로고
    • Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report
    • Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation, 2002, 106, 3143.
    • (2002) Circulation , vol.106 , pp. 3143


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.